- page

Domain Therapeutics and Medicxi launch Mavalon Therapeutics, aimed at halting the progression of Par...

Domain Therapeutics, Université de Montréal, IRICoR and McGill University extend licensing and par...

PeptiMimesis: New biotech startup developing next generation therapeutic peptides in immuno-oncology...